Abstract
Neuroanatomical structures may be profoundly or subtly affected by the interplay of genetic and environmental factors, age, and disease. Such effects are particularly true in healthy ageing individuals and in those who have neurodegenerative diseases. The ability to use imaging to identify structural brain changes associated with different neurodegenerative disease states would be useful for diagnosis and treatment. However, early in the progression of such diseases, neuroanatomical changes may be too mild, diffuse, or topologically complex to be detected by simple visual inspection or manually traced measurements of regions of interest. Computerised methods are being developed that can capture the extraordinary morphological variability of the human brain. These methods use mathematical models sensitive to subtle changes in the size, position, shape, and tissue characteristics of brain structures affected by neurodegenerative diseases. Neuroanatomical features can be compared within and between groups of individuals, taking into account age, sex, genetic background, and disease state, to assess the structural basis of normality and disease. In this review, we describe the strengths and limitations of algorithms of existing computer-assisted tools at the most advanced stage of development, together with available and foreseeable evidence of their usefulness at the clinical and research level.
Original language | English (US) |
---|---|
Pages (from-to) | 79-88 |
Number of pages | 10 |
Journal | Lancet Neurology |
Volume | 2 |
Issue number | 2 |
DOIs | |
State | Published - Feb 1 2003 |
Funding
JA is funded by the Wellcome Trust. JGC's contribution to this article was supported by Public Health Service (USA) grants MH/AG 60883 and MH 62130 and CD's was supported in part by NIH grant R01-AG-14971 and NIH contract AG-93-07. NCF is supported by the MRC (UK) through a Senior Clinical Fellowship, GBF by grants from the Italian national health service RF 00.343 from the Archivio Normativo Italiano di Morfometria Cerebrale con Risonanza Magnetica, and RA 00.61 from Decadimento Cognitivo Lieve non Dementigeno: Stadio Preclinico di Malattia di Alzheimer e Demenza Vascolare, and PMT by grants from the National Center for Research Resources (P41 RR13642), the National Library of Medicine (LM/MH05639), the National Institute of Neurological Disorders and Stroke and the National Institute of Mental Health (NS38753), and by the Human Brain Project (P20 MH/DA52176). No funding source had any influence over the preparation of the manuscript or any part in the decision to submit the paper for publication. JA, CD, GBF, and PMT have no conflicts of interest. JGC, in conjunction with Washington University and Medtronics Inc, holds a patent on a method for the neuromorphometry-based diagnosis of neuropsychiatric disorders. NCF has received financial support for imaging research from GlaxoSmithKline, Novartis, Janssen, and Elan.
ASJC Scopus subject areas
- Clinical Neurology